BRIEF published on 12/20/2024 at 07:05, 1 day 12 hours ago Innate Pharma at the 43rd JP Morgan Healthcare Conference Investors Immunotherapy Innate Pharma JP Morgan Conference Live Presentation
BRIEF published on 12/20/2024 at 07:05, 1 day 12 hours ago Innate Pharma à la 43ème J.P. Morgan Healthcare Conference Investisseurs Présentation En Direct Immunothérapie Innate Pharma J.P. Morgan Conference
PRESS RELEASE published on 12/20/2024 at 07:00, 1 day 12 hours ago Inside Information / Other news releases Innate Pharma to participate in the 43rd Annual J.P. Morgan Healthcare Conference with CEO Jonathan Dickinson and other executives presenting. Company focuses on developing immunotherapies for cancer patients Biotechnology Innate Pharma Immunothérapies Cancer Patients J.P. Morgan Healthcare Conference
PRESS RELEASE published on 12/20/2024 at 07:00, 1 day 12 hours ago Informations privilégiées / Autres communiqués Innate Pharma annonce sa participation à la 43ème J.P. Morgan Healthcare Conference avec présentations de ses dirigeants. Focus sur les traitements d'immunothérapies contre le cancer Cancer Innate Pharma Biotechnologies Immunothérapies J.P. Morgan Healthcare Conference
BRIEF published on 12/06/2024 at 07:05, 15 days 12 hours ago Innate Pharma: Investment of 7.9 million dollars for IPH6501 Investment Clinical Trial Innate Pharma IPH6501 Follicular Lymphoma
BRIEF published on 12/06/2024 at 07:05, 15 days 12 hours ago Innate Pharma : Investissement de 7,9 millions de dollars pour IPH6501 Investissement Essai Clinique Innate Pharma Lymphome Folliculaire IPH6501
PRESS RELEASE published on 12/06/2024 at 07:00, 15 days 12 hours ago Informations privilégiées / Autres communiqués Innate Pharma et l'Institut d'Innovation pour le Lymphome Folliculaire (IFLI) signent un accord d'investissement jusqu'à 7,9 millions de dollars pour le développement d'IPH6501 dans le lymphome folliculaire Investissement Innate Pharma Lymphome Folliculaire IPH6501 IFLI
BRIEF published on 11/20/2024 at 07:05, 1 month 1 day ago Innate Pharma unveils its financial calendar for 2025 Annual Results Innate Pharma Financial Calendar 2025 Assemblies And Publications Euronext And Nasdaq Contribution
BRIEF published on 11/20/2024 at 07:05, 1 month 1 day ago Innate Pharma dévoile son calendrier financier pour 2025 Résultats Annuels Innate Pharma Calendrier Financier 2025 Assemblées Et Publications Cotisation Euronext Et Nasdaq
PRESS RELEASE published on 11/20/2024 at 07:00, 1 month 1 day ago Informations privilégiées / Autres communiqués Innate Pharma publie son calendrier financier pour 2025 incluant les dates de publication des résultats et de l'assemblée générale, visant à informer les investisseurs et actionnaires Immunothérapie Événements Financiers Innate Pharma Biotechnologies Calendrier Financier 2025
Published on 12/21/2024 at 01:30, 18 hours 2 minutes ago Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 18 hours 2 minutes ago iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 19 hours 27 minutes ago Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/20/2024 at 23:30, 20 hours 2 minutes ago Boron One Announces Extension to Early Warrant Exercise Incentive Program
Published on 12/21/2024 at 00:51, 18 hours 41 minutes ago Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 47 minutes ago EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 18:00, 1 day 1 hour ago ARYZTA AG Announces New Board Technology Committee
Published on 12/21/2024 at 12:17, 7 hours 14 minutes ago AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 7 hours 14 minutes ago AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day 1 hour ago Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024
